Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Progressive MS”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Large-scale testing (Phase 3)Ended earlyNCT01416181
What this trial is testing

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Biogen 889
Not applicableStudy completedNCT03094364
What this trial is testing

Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisHemiparesis
University of Massachusetts, Lowell 31
Early research (Phase 1)WithdrawnNCT05029609
What this trial is testing

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisMultiple Sclerosis
Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,011
Not applicableEnded earlyNCT04746976
What this trial is testing

Study of Diroximel Fumarate in the Real-World Setting

Who this might be right for
Relapsing Forms of MS
Biogen 75
Not applicableLooking for participantsNCT07426991
What this trial is testing

Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting-Relapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis+3 more
Heinrich-Heine University, Duesseldorf 837
Not applicableActive Not RecruitingNCT03983681
What this trial is testing

Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

Who this might be right for
Multiple Sclerosis
Kessler Foundation 120
Testing effectiveness (Phase 2)Ended earlyNCT01212094
What this trial is testing

Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 44
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Not applicableLooking for participantsNCT07222618
What this trial is testing

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+3 more
University of California, San Francisco 300
Large-scale testing (Phase 3)Looking for participantsNCT07225504
What this trial is testing

Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals 1,275
Not applicableAvailableNCT06802328
What this trial is testing

Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients

Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Early research (Phase 1)UnknownNCT00220493
What this trial is testing

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisMultiple Sclerosis, Chronic Progressive
Sheba Medical Center 80
Post-approval studies (Phase 4)Study completedNCT02208050
What this trial is testing

The Effectiveness of Fampridine in Improving Upper Limb Function in MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
University College Dublin 64
Not applicableStudy completedNCT07264725
What this trial is testing

Libyan Multiple Sclerosis Registry Study

Who this might be right for
Multiple Sclerosis
University of Zintan 369
Testing effectiveness (Phase 2)Study completedNCT01191996
What this trial is testing

Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Innate Immunotherapeutics 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05441488
What this trial is testing

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
AB Science 800
Load More Results